Magnetically guided non-invasive CRISPR-Cas9/gRNA delivery across blood-brain barrier to eradicate latent HIV-1 infection

CRISPR-Cas9/gRNA exhibits therapeutic efficacy against latent human immunodeficiency virus (HIV) genome but the delivery of this therapeutic cargo to the brain remains as a challenge. In this research, for the first time, we demonstrated magnetically guided non-invasive delivery of a nano-formulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaushik, Ajeet, Yndart, Adriana, Atluri, Venkata, Tiwari, Sneham, Tomitaka, Asahi, Gupta, Purnima, Jayant, Rahul Dev, Alvarez-Carbonell, David, Khalili, Kamel, Nair, Madhavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408460/
https://www.ncbi.nlm.nih.gov/pubmed/30850620
http://dx.doi.org/10.1038/s41598-019-40222-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408460/
https://www.ncbi.nlm.nih.gov/pubmed/30850620
http://dx.doi.org/10.1038/s41598-019-40222-4

Ejemplares similares